Erythromycin Ethylsuccinate
- Product NDC
- 0254-1021
- 11-digit product format
- 002541021
- Labeler code
- 0254
- Product ID
- 0254-1021_8e0eeac7-cbc1-4d20-9f46-893a5f99fc4e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin Ethylsuccinate
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Labeler
- Par Pharmaceutical, Inc.
- Application
- ANDA211991
- Marketing category
- ANDA
- Marketing start
- 2019-11-27
- Marketing end
- 2021-09-30
- Substance
- ERYTHROMYCIN ETHYLSUCCINATE
- Active strength
- 400 mg/5mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0254-1021-47 | 00254102147 | 100 mL in 1 BOTTLE (0254-1021-47) | 100 ml | 2019-11-27 | 0000-00-00 | No | No | Current |